Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review
ContextSurgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation.ObjectiveTo systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current reco...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-11-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1287212/full |
| _version_ | 1797630678090645504 |
|---|---|
| author | Weixiang He Ting Ding Zhiping Niu Chunlin Hao Chengbin Li Zhicheng Xu Yuming Jing Weijun Qin |
| author_facet | Weixiang He Ting Ding Zhiping Niu Chunlin Hao Chengbin Li Zhicheng Xu Yuming Jing Weijun Qin |
| author_sort | Weixiang He |
| collection | DOAJ |
| description | ContextSurgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation.ObjectiveTo systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current recommendations and guidelines.Evidence acquisitionEligible studies published up to July 2023, were searched for in the PubMed® (National Library of Medicine, Bethesda, MD, USA), Embase® (Elsevier, Amsterdam, the Netherlands), and Web of Science™ (Clarivate™, Philadelphia, PA, USA) databases. STATA® (StataCorp LP, College Station, TX, USA) software was used to conduct the meta-analysis. Random-effects models were used to calculate the pooled incidences (PIs) of reoperation and the 95% confidence intervals (CIs).Evidence synthesisA total of 119 studies with 130,106 patients were included. The reoperation rate of transurethral resection of the prostate (TURP) at 1, 2, 3, and 5 years was 4.0%, 5.0%, 6.0%, and 7.7%, respectively. The reoperation rate of plasma kinetic loop resection of the prostate (PKRP) at 1, 2, 3, and 5 years was 3.5%, 3.6%, 5.7%, and 6.6%, respectively. The reoperation rate of holmium laser enucleation of the prostate (HoLEP) at 1, 2, 3, and 5 years was 2.4%, 3.3%, 5.4%, and 6.6%, respectively. The reoperation rate of photoselective vaporization of the prostate (PVP) at 1, 2, 3, and 5 years was 3.3%, 4.1%, 6.7%, and 7.1%, respectively. The reoperation rate of surgery with AquaBeam® at 1, 2, 3, and 5 years was 2.6%, 3.1%, 3.0%, and 4.1%, respectively. The reoperation rate of prostatic artery embolization (PAE) at 1, 2, 3, and 5 years was 12.2%, 20.0%, 26.4%, and 23.8%, respectively. The reoperation rate of transurethral microwave thermotherapy (TUMT) at 1, 2, 3, and 5 years was 9.9%, 19.9%, 23.3%, and 31.2%, respectively. The reoperation rate of transurethral incision of the prostate (TUIP) at 5 years was 13.4%. The reoperation rate of open prostatectomy (OP) at 1 and 5 years was 1.3% and 4.4%, respectively. The reoperation rate of thulium laser enucleation of the prostate (ThuLEP) at 1, 2, and 5 years was 3.7%, 7.7%, and 8.4%, respectively.ConclusionOur results summarized the reoperation rates of 10 surgical procedures over follow-up durations of 1, 2, 3, and 5 years, which could provide reference for urologists and LUTS patients.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier CRD42023445780. |
| first_indexed | 2024-03-11T11:11:34Z |
| format | Article |
| id | doaj.art-69634c77c2dc4b30bb49509718242a24 |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-03-11T11:11:34Z |
| publishDate | 2023-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-69634c77c2dc4b30bb49509718242a242023-11-11T22:34:42ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-11-011410.3389/fendo.2023.12872121287212Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic reviewWeixiang He0Ting Ding1Zhiping Niu2Chunlin Hao3Chengbin Li4Zhicheng Xu5Yuming Jing6Weijun Qin7Department of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Clinical Laboratory Medicine, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Environmental Health, School of Public Health, Fudan University, Shanghai, ChinaDepartment of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaDepartment of Urology, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaContextSurgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation.ObjectiveTo systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current recommendations and guidelines.Evidence acquisitionEligible studies published up to July 2023, were searched for in the PubMed® (National Library of Medicine, Bethesda, MD, USA), Embase® (Elsevier, Amsterdam, the Netherlands), and Web of Science™ (Clarivate™, Philadelphia, PA, USA) databases. STATA® (StataCorp LP, College Station, TX, USA) software was used to conduct the meta-analysis. Random-effects models were used to calculate the pooled incidences (PIs) of reoperation and the 95% confidence intervals (CIs).Evidence synthesisA total of 119 studies with 130,106 patients were included. The reoperation rate of transurethral resection of the prostate (TURP) at 1, 2, 3, and 5 years was 4.0%, 5.0%, 6.0%, and 7.7%, respectively. The reoperation rate of plasma kinetic loop resection of the prostate (PKRP) at 1, 2, 3, and 5 years was 3.5%, 3.6%, 5.7%, and 6.6%, respectively. The reoperation rate of holmium laser enucleation of the prostate (HoLEP) at 1, 2, 3, and 5 years was 2.4%, 3.3%, 5.4%, and 6.6%, respectively. The reoperation rate of photoselective vaporization of the prostate (PVP) at 1, 2, 3, and 5 years was 3.3%, 4.1%, 6.7%, and 7.1%, respectively. The reoperation rate of surgery with AquaBeam® at 1, 2, 3, and 5 years was 2.6%, 3.1%, 3.0%, and 4.1%, respectively. The reoperation rate of prostatic artery embolization (PAE) at 1, 2, 3, and 5 years was 12.2%, 20.0%, 26.4%, and 23.8%, respectively. The reoperation rate of transurethral microwave thermotherapy (TUMT) at 1, 2, 3, and 5 years was 9.9%, 19.9%, 23.3%, and 31.2%, respectively. The reoperation rate of transurethral incision of the prostate (TUIP) at 5 years was 13.4%. The reoperation rate of open prostatectomy (OP) at 1 and 5 years was 1.3% and 4.4%, respectively. The reoperation rate of thulium laser enucleation of the prostate (ThuLEP) at 1, 2, and 5 years was 3.7%, 7.7%, and 8.4%, respectively.ConclusionOur results summarized the reoperation rates of 10 surgical procedures over follow-up durations of 1, 2, 3, and 5 years, which could provide reference for urologists and LUTS patients.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier CRD42023445780.https://www.frontiersin.org/articles/10.3389/fendo.2023.1287212/fullbenign prostate hyperplasialower urinary tract symptomssurgeryretreatmentreoperation |
| spellingShingle | Weixiang He Ting Ding Zhiping Niu Chunlin Hao Chengbin Li Zhicheng Xu Yuming Jing Weijun Qin Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review Frontiers in Endocrinology benign prostate hyperplasia lower urinary tract symptoms surgery retreatment reoperation |
| title | Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review |
| title_full | Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review |
| title_fullStr | Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review |
| title_full_unstemmed | Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review |
| title_short | Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review |
| title_sort | reoperation after surgical treatment for benign prostatic hyperplasia a systematic review |
| topic | benign prostate hyperplasia lower urinary tract symptoms surgery retreatment reoperation |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1287212/full |
| work_keys_str_mv | AT weixianghe reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT tingding reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT zhipingniu reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT chunlinhao reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT chengbinli reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT zhichengxu reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT yumingjing reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview AT weijunqin reoperationaftersurgicaltreatmentforbenignprostatichyperplasiaasystematicreview |